Q4 Results May 22 Today ITC Sun Pharma GMR Grasim 1747894297695 1747894298053

Q4 results today: ITC, Sun Pharma, GMR Airports, Grasim, Ramco Cements, Concor, Honasa, and Gujarat Petronet on May 22

Q4 results today, on May 22: ITC, Sun Pharma, Grasim, GMR Airports, Container Corporation of India (CONCOR), Barbeque Nation, Honasa Consumer, Gujarat State Petronet, Ramco Cements, and Sundaram Finance are among at least 142 companies scheduled to release their earnings report on Thursday. Keen trackers will be waiting for any corporate announcements, revenue outlooks, share…

Read More
Dharmesh Shah 2022 03 1708927453301 1746948108904

Stocks to buy or sell: Dharmesh Shah of ICICI Securities suggests buying Sun Pharma shares on 12 May 2025

Stock market news: Indian stock markets in the week ahead, starting Monday, will be influenced by geopolitical events, especially the ongoing tensions with Pakistan, along with macroeconomic indicators and corporate earnings, according to market analysts. The Nifty 50 wrapped up the week at 24,008.00, reflecting a decrease of 1.39%, while the Sensex closed at 79,454.47,…

Read More
Dharmesh Shah 2022 03 1708927453301 1746304860774

Stocks to buy or sell: Dharmesh Shah of ICICI Securities suggests buying Sun Pharma shares on 5 May 2025

Stock market news: The domestic equity market benchmark indices, Sensex and Nifty 50, saw a minor uptick on Friday, ending off day’s high, as investors resorted to profit-booking at higher levels. Optimism surrounding a potential India-US trade deal, record high April GST collection, and continuous inflow of foreign funds, was offset by potential geopolitical tensions…

Read More
Drugs 1744201293942 1744201294238

US tariffs on Pharma: Dr Reddy’s to Sun Pharma—can Indian drugmakers escape Trump’s tariff tantrums?

US tariffs on Pharma: US President Donald Trump announced that tariffs on pharmaceutical product imports will be announced soon. The products have been exempted from the tariffs announced to date. While the move seems to be largely aimed at Ireland and China, Indian pharma companies with significant exposure to the US may still face challenges….

Read More
Enable Notifications OK No thanks